Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin
Stefan Zeuzem
, Ira M. Jacobson
, Tolga Baykal
, Rui T. Marinho
,
Fred Poordad
, Marc Bourlier̀e
, Mark S. Sulkowski
, Heiner Wedemeyer
, Edward Tam
, Paul Desmond
, Donald M. Jensen
, Adrian M. Di Bisceglie
, Peter Varunok
, Tarek Hassanein
, Junyuan Xiong
, Tami Pilot-Matias
, Barbara DaSilva-Tillmann
, Lois Larsen
, Thomas Podsadecki
, Barry Bernstein
UT Health San Antonio Transplant Center
Division of Gastroenterology
Research output
:
Contribution to journal
›
Article
›
peer-review
517
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Patient
100%
Ribavirin
35%
Ritonavir
23%
Ombitasvir
23%
Infection
17%
Retreatment
17%
Peginterferon
17%
Dasabuvir
17%
Interferon
11%
Liver Cirrhosis
11%
Sustained Virologic Response
11%
Placebo
11%
Relapse
11%
Confidence Interval
5%
Hemoglobin
5%
Drug Dose
5%
Adverse Event
5%
Pruritus
5%
Telaprevir
5%
Drug
5%
Control
5%
Inpatient
5%
Analysis
5%
Blindness
5%
Dose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Ribavirin
35%
Ritonavir
23%
Ombitasvir
23%
Infection
17%
Peginterferon
17%
Dasabuvir
17%
Interferon
11%
Liver Cirrhosis
11%
Relapse
11%
Adverse Event
5%
Hemoglobin
5%
Drug
5%
Telaprevir
5%
Pruritus
5%
Blindness
5%